{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:19:56Z","timestamp":1777763996113,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2006101"],"award-info":[{"award-number":["GNT2006101"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2009840"],"award-info":[{"award-number":["GNT2009840"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ygyno.2025.11.023","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:06:12Z","timestamp":1764943572000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating patient perspectives about the acceptability of a novel prognostic gene expression signature for high grade serous ovarian cancer: The OTTA-SPOT study"],"prefix":"10.1016","volume":"204","author":[{"given":"Holly E.","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber-Marie","family":"Firriolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Houweling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Kelada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gill","family":"Stannard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinta","family":"Frawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany C.","family":"McGill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Ramus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeh Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire E.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.11.023_bb0005","series-title":"Cancer Data in Australia","author":"Health, A.I.o.; Welfare","year":"2024"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0010","series-title":"Proceedings of the Seminars in Oncology Nursing","first-page":"151","article-title":"Ovarian cancer: an integrated review","author":"Stewart","year":"2019"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0015","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.21873\/anticanres.16273","article-title":"Efficacy and safety of platinum-based chemotherapy with bevacizumab followed by bevacizumab maintenance for recurrent ovarian, fallopian tube, and primary peritoneal Cancer during PARP inhibitor therapy: A multicenter retrospective study","volume":"43","author":"Abe","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0020","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41598-022-06230-7","article-title":"A framework to predict the applicability of Oncotype DX, MammaPrint, and E2F4 gene signatures for improving breast cancer prognostic prediction","volume":"12","author":"Yao","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40364-025-00818-7","article-title":"Therapeutic landscape of ovarian cancer: recent advances and emerging therapies","volume":"13","author":"Wang","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0030","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.annonc.2020.05.019","article-title":"Prognostic gene expression signature for high-grade serous ovarian cancer","volume":"31","author":"Millstein","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00428-024-03807-7","article-title":"Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma","volume":"486","author":"Zelisse","year":"2025","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0269216308098799","article-title":"Advanced cancer patients\u2019 prognostic information preferences: a review","volume":"23","author":"Innes","year":"2009","journal-title":"Palliat. Med."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/10410236.2023.2210383","article-title":"Cultivating relationship-centered care: patient, caregiver, and provider communication preferences for and experiences with prognostic conversations","volume":"39","author":"Haverfield","year":"2024","journal-title":"Health Commun."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282180","article-title":"When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review","volume":"18","author":"Wreyford","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0060","first-page":"76","article-title":"Improving healthcare through the use of co-design","volume":"125","author":"Boyd","year":"2012","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ebiom.2018.10.060","article-title":"The avatar acceptability study: survivor, parent and community willingness to use patient-derived xenografts to personalize cancer care","volume":"37","author":"Wakefield","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0075","first-page":"7","article-title":"Avatar acceptability: views from the Australian cystic fibrosis community on the use of personalised organoid technology to guide treatment decisions","author":"Fawcett","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0080","series-title":"Thematic Analysis: A Practical Guide","author":"Braun","year":"2021"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2023.151502","article-title":"Scan-associated distress in people affected by Cancer: A qualitative systematic review","volume":"39","author":"Hussain","year":"2023","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0090","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2015.61.9239","article-title":"Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced Cancer","volume":"33","author":"Enzinger","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1188\/19.CJON.478-481","article-title":"Breast Cancer prognostic tests: helping patients understand testing results and their implications","volume":"23","author":"Miller","year":"2019","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ygyno.2019.07.026","article-title":"Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide","volume":"155","author":"Littell","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bmjspcare-2021-003313","article-title":"Prognostic disclosure in oncology - current communication models: a scoping review","volume":"12","author":"Bloom","year":"2022","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2648.2012.06064.x","article-title":"What are the core elements of patient-centred care? A narrative review and synthesis of the literature from health policy, medicine and nursing","volume":"69","author":"Kitson","year":"2013","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.ygyno.2025.11.023_bb0115","author":"Australian Institute of Health and Welfare"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0120","author":"Australian Bureau of Statistics"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0125","author":"Australian Bureau of Statistics"},{"key":"10.1016\/j.ygyno.2025.11.023_bb0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0272989X16638321","article-title":"Factors affecting physicians\u2019 intentions to communicate personalized prognostic information to cancer patients at the end of life: an experimental vignette study","volume":"36","author":"Han","year":"2016","journal-title":"Med. Decis. Mak."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825011187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825011187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:29Z","timestamp":1777474709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825011187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S0090825825011187"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.11.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating patient perspectives about the acceptability of a novel prognostic gene expression signature for high grade serous ovarian cancer: The OTTA-SPOT study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}